These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6695814)

  • 1. Evaluation of flecainide acetate in the management of patients at high risk of sudden cardiac death.
    Reid PR; Griffith LS; Platia EV; Ord SE
    Am J Cardiol; 1984 Feb; 53(5):108B-111B. PubMed ID: 6695814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia.
    Platia EV; Estes M; Heine DL; Griffith LS; Garan H; Ruskin JN; Reid PR
    Am J Cardiol; 1985 Apr; 55(8):956-62. PubMed ID: 3984883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of resistant ventricular tachycardia with flecainide acetate. Flecainide Ventricular Tachycardia Study Group.
    Am J Cardiol; 1986 Jun; 57(15):1299-304. PubMed ID: 3717029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flecainide in the treatment of nonsustained ventricular tachycardia.
    Lal R; Chapman PD; Naccarelli GV; Schechtman KB; Rinkenberger RL; Troup PJ; Kim SS; Dougherty AH; Ruffy R
    Ann Intern Med; 1986 Oct; 105(4):493-8. PubMed ID: 3752754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Can sudden cardiac death be prevented by treatment with anti-arrhythmia drugs?].
    Zrenner B; Koller B; Rudolph W
    Herz; 1990 Apr; 15(2):90-102. PubMed ID: 2188895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New aspects of the clinical use of anti-arrhythmia agents with special reference to acute therapy of ventricular tachycardia (lidocaine vs. ajmaline)].
    Manz M; Mletzko R; Jung W; Lüderitz B
    Herz; 1990 Apr; 15(2):79-89. PubMed ID: 2188894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral flecainide for suppression of ventricular arrhythmias.
    Vanhaleweyk G; Balakumaran K; Lubsen J; Roelandt J; Hugenholtz PG
    Cardiology; 1984; 71(1):30-9. PubMed ID: 6722846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of flecainide on ventricular function: clinical and experimental correlations.
    Josephson MA; Ikeda N; Singh BN
    Am J Cardiol; 1984 Feb; 53(5):95B-100B. PubMed ID: 6695822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intravenous and oral flecainide on ventricular tachycardia.
    Ward DE; Cheesman M; Dancy M
    Int J Cardiol; 1986 Mar; 10(3):251-62. PubMed ID: 3957470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification by type of ventricular arrhythmia predicts frequency of adverse cardiac events from flecainide.
    Morganroth J; Anderson JL; Gentzkow GD
    J Am Coll Cardiol; 1986 Sep; 8(3):607-15. PubMed ID: 3745706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia.
    Rinkenberger RL; Naccarelli GV; Berns E; Dougherty AH
    Am J Cardiol; 1988 Aug; 62(6):44D-55D. PubMed ID: 3136636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Flecainide: a new antiarrhythmic agent].
    Leclercq JF; Coumel P
    Arch Mal Coeur Vaiss; 1983 Oct; 76(10):1218-30. PubMed ID: 6418100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flecainide: long-term treatment using a reduced dosing schedule.
    Flowers D; O'Gallagher D; Torres V; Miura D; Somberg JC
    Am J Cardiol; 1985 Jan; 55(1):79-83. PubMed ID: 3966401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flecainide: steady state electrophysiologic effects in patients with remote myocardial infarction and inducible sustained ventricular arrhythmia.
    Webb CR; Morganroth J; Senior S; Spielman SR; Greenspan AM; Horowitz LN
    J Am Coll Cardiol; 1986 Jul; 8(1):214-20. PubMed ID: 3711519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Electrophysiological effects of flecainide on stimulus-inducible ventricular tachycardia].
    Breithardt G; Borggrefe M; Yeh HL; Seipel L
    Z Kardiol; 1982 Apr; 71(4):278-83. PubMed ID: 7090468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with electrophysiologically guided therapy of ventricular tachycardia with flecainide: summary of long-term follow-up.
    Anderson JL
    Am J Cardiol; 1984 Feb; 53(5):79B-86B. PubMed ID: 6695820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short- and long-term experience with flecainide acetate in the management of refractory life-threatening ventricular arrhythmias.
    Lal R; Chapman PD; Naccarrelli GV; Troup PJ; Rinkenberger RL; Dougherty AH; Ruffy R
    J Am Coll Cardiol; 1985 Oct; 6(4):772-9. PubMed ID: 3928725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flecainide: a new antiarrhythmic drug.
    Mueller RA; Baur HR
    Clin Cardiol; 1986 Jan; 9(1):1-5. PubMed ID: 3510788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Estimation of the long-term efficacy of anti-arrhythmia treatment with flecainide in ventricular tachycardia].
    Fauchier JP; Cosnay P; Babuty B; Moquet B; Rouesnel P; Estepo J
    Arch Mal Coeur Vaiss; 1990 Jan; 83(1):77-83. PubMed ID: 2106308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flecainide: a new prototype antiarrhythmic agent.
    Nappi JM; Anderson JL
    Pharmacotherapy; 1985; 5(4):209-21. PubMed ID: 3898035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.